ACT EU is developing a training curriculum informed by regulatory experience to support high quality clinical trials and enable better knowledge sharing.
An overarching strategy and collection of training needs for different stakeholders will serve as the basis for the development of curricula.
Engaging with stakeholders, the curriculum aims to feed into an educational ‘ecosystem’ to enable targeted training on clinical trials.
Report on clinical trials training needs of academia and SMEs
In early 2025, ACT EU conducted a survey to assess the clinical trials training needs of academia and micro, small and medium-sized enterprises (SMEs) involved in the research and/or development of medicines for human use.
The feedback from around 400 stakeholders was analysed and published in a report that outlines key training needs, identifies potential gaps as well as challenges and suggests ways to address them.
As a next step, ACT EU will map and signpost the most important clinical trials trainings. The aim is to support stakeholders in navigating available resources more effectively.
Related documents
A training strategy is available, setting out high-level objectives for the development of a training curriculum. The document highlights the importance of accessing appropriate expertise in medicines development.
A summary of the gap analysis on training needs of regulators involved in clinical trial assessment is also available.
